Effect of single botulinum toxin a injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury

Journal of Rehabilitation Medicine

Volumn 40, Issue 9, 2008, Pages 744-748

  Chen, Sung Lang ^a   Bih, Liu Ing ^a   Huang, Yu Hui ^a   Tsai, Su Ju ^a   Lin, Tzer Bin ^b   Kao, Yu Lin ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Botulinum toxin; Neurogenic bladder; Urethral sphincter; Urodynamic study

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; DOXAZOSIN MESYLATE; SCOPOLAMINE BUTYL BROMIDE; TERAZOSIN; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; BLADDER PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DETRUSOR DYSSYNERGIA; DRUG EFFICACY; DRUG RESPONSE; ELECTROMYOGRAPHY; FEMALE; HEMATURIA; HUMAN; MALE; OPEN STUDY; POSTVOID RESIDUAL URINE VOLUME; SINGLE DRUG DOSE; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URETHRA PRESSURE; INJECTION; MICTURITION DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; SPASTICITY; URETHRA; URETHRA DISEASE; URODYNAMICS;

ADULT; BOTULINUM TOXIN TYPE A; CYSTOSCOPY; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; SPINAL CORD INJURIES; TREATMENT OUTCOME; URETHRA; URETHRAL DISEASES; URINATION DISORDERS; URODYNAMICS;

EID: 54049146388     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0255     Document Type: Article

References (33)

1. Blaivas JG, Sinha HP, Zayed AA, Labib KB. Detrusor-external sphincter dyssynergia. J Urol 1981; 125: 542-544.
2. Blaivas JG, Barbalias GA. Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol 1984; 131: 91-94.
3. Thomas DG, editor. Spinal cord injury. New York: Churchill Livingstone; 1984, p. 259-272.
4. Lin, VW, editor. Spinal cord medicine: principles and practice. New York: Demos Medical Publishing, Inc.; 2003, p. 299.
5. Yang CC, Mayo ME. External urethral sphincterotomy: long-term follow-up. Neurourol Urodyn 1995; 14: 25-31.
6. Chancellor MB, Rivas DA, Linsenmeyer T, Abdill CA, Ackman CF, Appell RA, et al. Multicenter trial in North America of UroLume urinary sphincter prosthesis. J Urol 1994; 152: 924-930.
7. Chancellor MB, Erhard MJ, Rivas DA. Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function. J Am Paraplegia Soc 1993; 16: 207-214.
8. Perkash I, Giroux J. Clean intermittent catheterization in spinal cord injury patients: a followup study. J Urol 1993; 149: 1068-1071.
9. Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003; 44: 165-174.
10. Scott AB, Kennedy RA, Stubbs HA. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985; 103: 347-350.
11. Tsui JK, Calne DB. Botulinum toxin in cervical dystonia. Adv Neurol 1988; 49: 473-478.
12. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 1994; 103: 31-35.
13. Hesse S, Lucke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994; 57: 1321-1324.
14. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988; 139: 919-922.
15. Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 1990; 71: 24-26.
16. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996; 155: 1023-1029.
17. Petit H, Wiart L, Gaujard E, Le Breton F, Ferriere JM, Lagueny A, et al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998; 36: 91-94.
18. de Seze M, Petit H, Gallien P, de Seze MP, Joseph PA, Mazaux JM, et al. Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol 2002; 42: 56-62.
19. Kuo HC. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003; 170: 1908-1912.
20. Gallien P, Robineau S, Verin M, Le Bot MP, Nicolas B, Brissot R. Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin. Arch Phys Med Rehabil 1998; 79: 715-717.
21. Wheeler JS, Jr, Walter JS, Chintam RS, Rao S. Botulinum toxin injections for voiding dysfunction following SCI. J Spinal Cord Med 1998; 21: 227-229.
22. Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001; 165: 1107-1110.
23. Sleivert GG, Wenger HA. Reliability of measuring isometric and isokinetic peak torque, rate of torque development, integrated electromyography, and tibial nerve conduction velocity. Arch Phys Med Rehabil 1994; 75: 1315-1321.
24. Weber S, Muravchick S. Monitoring technique affects measurement of recovery from succinylcholine. J Clin Monit 1987; 3: 1-5.
25. Chamberlain DP, Crawford RD. Integrated electromyographic measurement of abdominal motor blockade during bupivacaine epidural anesthesia for lower abdominal and pelvic surgery. Anesth Analg 1987; 66: 57-63.
26. Abrams P, Feneley R, Torrens M, editors. Urodynamics. Berlin: Springer-Verlag; 1983, p. 60.
27. Yalla SV, McGuire EJ, Elbadawi A, Blaivas JG, editors. Neurourology and urodynamics: principles and practice. New York: MacMillan Publishing Co.; 1988, p. 49.
28. Mundy AR, Stephenson TP, Wein AJ, editors. Urodynamics: principles, practice and application. 2nd edn. New York: Churchill Livingstone; 1994, p. 148.
29. Plevnik S, Janez J. Urethral pressure variations. Urology 1983; 21: 207-209.
30. Kimura J, editor. Electrodiagnosis in diseases of nerve and muscle: principles and practice. 3rd edn. New York: Oxford University Press, Inc.; 2001, p. 35 and 326.
31. Cote RJ, Burke H, Schoenberg HW. Prediction of unusual postoperative results by urodynamic testing in benign prostatic hyperplasia. J Urol 1981; 125: 690-692.
32. McGuire EJ, Cespedes RD, O'Connell HE. Leak-point pressures. Urol Clin North Am 1996; 23: 253-262.
33. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692-697.